UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  May 23, 2007
                                                 -------------------------------

                              POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         Minnesota                       0-944                    41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File Number)         (IRS Employer
      of incorporation)                                      Identification No.)


9055 Evergreen Boulevard NW, Minneapolis, MN                       55433-8003
- --------------------------------------------------------------------------------
 (Address of principal executive offices)                          (Zip Code)


Registrant's telephone number, including area code  763-780-4555
                                                   -----------------------------

                                 Not Applicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))




     Section 9 - Financial Statements and Exhibits

          Item 9.01 Possis Medical, Inc., Reports Quarterly Financial Results


     On May 23, 2007, the Company issued a press release reporting operating
     results for its fiscal year 2007 third quarter ending April 30, 2007. A
     copy of the press release is furnished as Exhibit 99.1 to this Report and
     is incorporated herein by reference.


     [c] Exhibits

     99.1 Press Release, dated May 23, 2007, issued by Possis Medical, Inc.



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Possis Medical, Inc.
- --------------------
(Registrant)

Date: May 23, 2007
      ------------

By: /s/ Jules L. Fisher
    ---------------------------------------------------
    Jules L. Fisher
    Vice President, Finance and Chief Financial Officer




                                  EXHIBIT INDEX

Exhibit No.    Description
- -----------    -----------

99.1           Press Release, dated May 23, 2007, issued by Possis Medical, Inc.